When & How to Use Changed Clinical Laboratory Consult Codes
Use of these codes has frequently raised concerns for compliance due to a lack of clarity regarding when they’re appropriate.
Use of these codes has frequently raised concerns for compliance due to a lack of clarity regarding when they’re appropriate.
On Jan. 11, the FDA warned consumers not to use COVID-19 tests from LuSys Laboratories, as they have not been approved for use in the US.
Here’s a look at the key takeaways from the Dec. 30 OIG report on Medicare Part B spending on lab testing.
Labs that bill federal health care programs for these tests need to pay especially close attention to ensure compliance.